Is India finally reaching a turning point in cervical cancer prevention?

Know more→

Healthcare & Lifesciences

Healthcare and Lifesciences

Is india finally reaching a turning point in cervical cancer prevention?

11 Feb 2026

1 min read

India’s HPV vaccine market reached ?91 Cr. in early 2026, marking a significant revival in preventive healthcare.

While digital platforms have eased access for urban women aged 26–35, the high cost of doses—ranging from ?1.5K to ?11K—remains a barrier.

Experts suggest that true scale requires the inclusion of vaccines in national immunization programs to bridge the urban-rural divide.

Read more at Mint

Disclaimer: The text, images and content here have been reproduced from the original publisher. Praxian Global Private Limited does not claim any ownership or right to use of this content and the rights belong to the publisher. We have contributed our perspectives, which are often proprietary, to the content publisher. We or the publisher have no obligation to update or refresh the content or our perspectives shared herein.

Ready to talk?

I want to talk to your experts in:

We work with ambitious leaders and transformative clients who are defining the future. Together, we achieve extraordinary outcomes.